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Abstract
Heat shock protein 90 (Hsp90) is a highly essential molecular chaperone that regulates 
the maturation and activity of its client proteins. Our goal was to analyse the potential role 
of Hsp90 in ethylene pathway by characterizing its interaction with Ethylene Sensor 2 
(ERS2), whose function is perception and transduction of ethylene in Arabidopsis 
thaliana. Here, we identified ERS2 as a client protein and characterized the Hsp90-ERS2 
interaction using yeast two-hybrid and Bimolecular Fluorescence Complementation 
approaches. Based on our findings, ERS2 interacts with Hsp90 via its kinase domain and 
Hsp90 regulates the stability o f ERS2. These data will expand our knowledge of Hsp90 
function in regulating ethylene signalling as one of the important plant growth regulators, 
due to its role in fruit ripening and stress response. The ability to manipulate ethylene 
signaling in plants is important for the possible downstream applications of this finding.
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1.1 The heat shock protein family
In 1962, Ritossa et al. reported the effect of high temperature on the puffing patterns of 
the salivary gland chromosomes of Drosophila (Ritossa et al., 1962). They observed 
similar effects after treatment with chemicals such as 2, 4-dinitrophenol and sodium 
salicylate. These observations indicated that chemical compounds and high temperatures 
could induce the expression of a set o f unknown genes. A few years later, the products 
o f these genes were identified as heat shock proteins (Hsps) based on the stimulus that 
caused their expression (Tissieres et al., 1974). As their name implies, Hsps are induced 
by high temperatures and also by a variety o f other stresses such as toxins, heavy metals, 
reactive oxygen species, environmental stresses, and pathogens. In addition, Hsps are 
also expressed under normal physiological conditions (Akerfelt et al., 2010). Thus, 
within an Hsp gene family, some members are stress-induced while others are 
constitutively expressed.
Based primarily on their molecular masses and functional mechanisms, Hsps are divided 
into six major classes: HsplOO, Hsp90, Hsp70, Hsp60, Hsp40 and the small heat shock 
protein family (sHsp) (Kampinga et al., 2009). Molecular chaperoning is the major 
function of Hsps. They perform basic and essential cell functions under normal 
conditions, such as facilitating newly synthesized polypeptides to fold properly into their 
biologically native structure. During stress, Hsps protect cellular proteins from 
denaturation, assist partially denatured proteins to refold and prevent aggregation of 
denatured proteins. The induction of Hsps in response to stress requires the activation of 
heat shock transcription factors (HSFs), which bind to heat shock elements (HSEs)
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present in the promoters of target genes and activate transcription of Hsps (Yamamoto et 
al., 2009). There are 21 HSFs in Arabidopsis thaliana, including the major regulator of 
Hsps, HSF-1 (Nover et al., 2001).
1.2 Heat shock protein 90
The highly conserved 90 kDa heat shock protein (Hsp90) is an abundant protein, 
representing 1-2% of the total cellular protein under normal conditions, and 4-6% in 
stressed cells of bacteria, yeast and eukaryotes (Craig et al., 1993). Genomic studies in 
Saccharomyces cerevisiae suggested that up to 10% of all cellular proteins are directly 
or indirectly dependent on Hsp90 for function (McClellan et al., 2007). An Hsp90 
‘client’ is defined as an Hsp90-interacting protein that uses the Hsp90 chaperone 
machinery for its folding, maturation, stabilization and/or functional regulation. Hsp90 
is a unique molecular chaperone in that the majority of its client proteins are signal 
transduction proteins. In animal systems, Hsp90 client proteins include steroid hormone 
receptors and a variety of protein kinases (Taipale et al., 2010). Hsp90 also plays an 
important role during stress. When stress occurs, Hsp90 stabilizes partially unfolded 
proteins, preventing them from aggregating (Peterson et al., 2009).
Hsp90 has been extensively studied, but much of our knowledge on Hsp90 interactions 
with other proteins comes from studies on mammalian cells. Mammalian cells possess 
three types o f Hsp90s: 1) cytosolic Hsp90 that has two isoforms, Hsp90-a and Hsp90-(3, 
which are 76% identical in amino acid sequence; 2) mitochondrial Trap-1; and 3) Grp94 
in the endoplasmic reticulum (ER) (Felts et al., 2000). In A. thaliana, four proteins 
constitute the cytoplasmic subfamily, and three others localize to the plastid, 
mitochondria and ER (Krishna & Gloor, 2001). The homologue of Hsp90 in prokaryotic
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cells is a single protein referred to as high temperature protein G (HtpG) that is 42% 
identical in amino acid sequence to human Hsp90 (Csermely et al., 1998).
1.3 Hsp90 structure and mode of action
Biochemical and crystallographic studies have found that eukaryotic Hsp90 functions as 
a homodimer in vivo and consists o f three domains: the N-terminal ATP-binding 
domain, which is highly conserved across all species and is responsible for the ATPase 
activity o f Hsp90; the middle domain that is considered to be the major site for client 
protein binding; and the C-terminal dimerization domain (Figure 1) (Pearl et al., 2008). 
There is also a charged region, which is variable in length and amino acid composition 
in different species, and serves as a flexible linker between the N-terminal and middle 
domains. The C-terminal domain serves as a dimerization site and is also involved in the 
formation o f active Hsp90 multiprotein complexes via the conserved pentapeptide 
MEEVD sequence, which is responsible for interacting with the tetratricopeptide repeat 
(TPR) domain o f several Hsp90 co-chaperones (Pratt & Toft, 2003).
ATP binding and hydrolysis are critical for Hsp90 function and result in Hsp90 
conformational changes (Pearl et al., 2008). In the “open state” of Hsp90 the N-terminal 
domains are separated, allowing for loading o f the client protein in the middle region. 
Upon binding ATP, a conformational change occurs that leads to dimerization of 24 
amino acids in the N-terminal region and lid closure, thus achieving the “closed state” of 
the complex (Figure 2). The final maturation of the client protein takes place with the 
coordinated help o f several co-chaperones in dynamic protein heterocomplexes. Once 
the ATP is hydrolysed, the heterocomplex dissociates and the client protein is released. 
Several Hsp90-specific inhibitors, such as geldanamycin (GA) and radicicol (RA), bind
Figure 1: Domain structure o f human Hsp90. Yellow: N-terminal domain which is 
mainly responsible for ATP binding, blue: linker domain, green: middle region that is the 
main site for loading o f the client proteins, dark blue: C-terminus which is responsible for 
homodimerization, and the pentapeptide MEEVD domain which is responsible for 
protein-protein interaction.
ATP binding site Dimerization site
substrate binding sites
Figure 2: ATPase cycle o f Hsp90: Upon ATP binding, gamma phosphate interacts with 
the middle region and a conformational change occurs from the open state to the closed 
state, which is reversed upon ATP hydrolysis.
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tightly to the ATP/ADP pocket and inactivate Hsp90, which leads to the destabilization 
and degradation of the client protein (Trepel et al., 2010). These drugs have therefore 
proved to be valuable tools in the study o f  Hsp90 client proteins.
1.4 Hsp90 co-chaperones
Hsp90 functions as the core component o f a dynamic set o f multiprotein complexes 
containing co-chaperones and other molecular chaperones such as Hsp70 to promote 
folding, functional maturation, and stability o f its client proteins. Hsp90 co-chaperones 
regulate the ATPase activity o f Hsp90 (Caplan et al., 2007), and confer specificity to the 
interaction o f Hsp90 with different client proteins (Brown et al., 2007). The majority of 
Hsp90 co-chaperones were identified by co-purification with Hsp90 complexes and can 
be categorized into two groups based on their structure: 1) co-chaperones that possess a 
conserved TPR domain; and 2) co-chaperones that do not contain a TPR domain. The 
TPR domain consists o f a degenerate 34 amino acid repeat with a conserved pattern of 
amino acid similarity which is often arranged in tandem arrays ranging from 3-16. These 
repeats represent highly conserved three-dimensional structures that form scaffolds to 
mediate protein-protein interactions (Sikorski et al., 1990). X-ray crystallographic 
structures o f TPR domains in Hsp70-Hsp90 organizing protein (Hop), in complex with 
C-terminal peptides o f Hsp70 and Hsp90 containing the highly conserved EEVD motif, 
revealed that a subset o f basic residues in the TPR domain form a so-called ‘carboxylate 
clamp’ that interacts with the acidic side chains on the peptide ligand. These basic 
amino acid positions are conserved in other co-chaperones of Hsp90 that contain TPR 
domains (Carrigan et al., 2006). The TPR co-chaperones of Hsp90 include 
immunophilins [FK Binding Protein 51 (FKBP51) and FKBP52, Cyclophilin 40
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(Cyp40)], Hop, protein phosphatase 5 (PP5) and the carboxyl terminus of Hsc70 
interacting protein (CHIP). The second group consists of co-chaperones such as p23, 
activator o f Hsp90 ATPase 1 (AHA1), and Suppressor of G2 allele of skpl (SGT1) 
(Zuehlke & Johnson, 2010). The majority of the known above-mentioned co-chaperones 
o f Hsp90 in other organisms are conserved in plants (Prasad et al., 2010).
1.5 Hsp90-substrate interaction
In animal systems, Hsp90 clients include steroid hormone receptors, tyrosine kinases 
such as pp60, serine/threonine kinases such as cyclin-dependent kinase 4 (Cdk4), as well 
as other signal transduction proteins and transcription factors (Taipale et al., 2010). An 
up to date list o f Hsp90 clients is maintained by Dr. D. Picard at 
http://www. picard. ch/downloads/Hsp90interactors.pdf. The maturation o f the client 
protein occurs in a complex multi-step process in which Hsp90 interacts with co­
chaperones in a sequential fashion and forms a cyclic chaperone pathway. However, it is 
unclear how Hsp90 recognizes and interacts with such a diverse set of client proteins. 
According to the steroid hormone receptor model, the receptor is converted from a non­
functional protein to an active receptor and transcription factor. In this well 
characterized example, Hsp70 first binds to the client protein (steroid hormone receptor) 
together with its co-chaperone Hsp40. Subsequently, Hop binds to the C-terminal 
domains o f Hsp70 and Hsp90 via its TPR domain, bringing the two molecular 
chaperones in the vicinity o f each other to form an “intermediate chaperone complex” in 
which Hop functions to inhibit the ATPase activity o f Hsp90. Then Hsp70 and Hop 
dissociate while p23 and immunophilins enter the complex to stabilize it and link it to 
the cytoplasmic dynein complex, which moves the receptor-Hsp90 complex to the
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nucleus (Pratt et al., 2008). The hormone-bound receptor binds to the promoter of target 
genes and triggers the hormone response.
1.6 Hsp90 inhibitors and their mode of action
GA and RA are natural compounds that mimic the binding of ATP to the N-terminal 
domain o f Hsp90; this was confirmed by X-ray crystallography (Stebbins et al., 1997). 
The antibiotic GA was originally isolated from Streptomyces hygroscopicus (Deboer et 
al., 1970) and belongs to the family o f benzoquinone ansamycins. It binds to the ATP- 
binding pocket o f Hsp90 with higher affinity than ATP and ADP, and prevents the 
nucleotide-mediated Hsp90 switching between its open and closed conformation. 
Prevention of this conformational change, blocks the activation of Hsp90 client proteins 
in vivo. These unprocessed proteins accumulate within the cell, leading to the 
recruitment of E3 ubiquitin ligases that target Hsp90 client proteins for degradation via 
the proteasome pathway (Maloney & Workman, 2002). RA, another inhibitor o f Hsp90, 
was isolated from Monosporium bonarden (Delmotte & Delmotte-Plaque, 1953). RA 
has a different structure from GA and binds to the N-terminal ATP pocket of Hsp90 
with even greater affinity than GA (Prodromou et al., 1997). There are several other 
Hsp90 inhibitors such as 17-allylamino-17-demethoxygeldanamycin (17-AAG), 17- 
dimethylaminoethylamino-17-demethoxygeldanamycin (17DMAG) and novobiocin, all 
o f which have been demonstrated to inhibit the function o f Hsp90 (Richardson et al., 
2011).
1.7 Hsp90 as a target for anti-tumour drugs
Targeting Hsp90’s activity by GA, RA or other such inhibitors leads to degradation of 
many over-expressed mutated oncoproteins (Richardson et al., 2011), which is why
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Hsp90 has been suggested as a unique target for cancer therapeutics. Hsp90 and its co­
chaperones are over-expressed in tumour cells, suggesting that a greater amount of 
Hsp90 is engaged in active chaperoning in these cells, leading to stabilization of 
aberrant signalling proteins and ultimately to tumour cell survival (Richardson et al., 
2011). The cancer cells utilize the Hsp90-based-chaperone machinery to protect over­
expressed oncoproteins from degradation. In addition, Hsp90 in tumour cells has a 
higher ATPase activity and affinity for inhibitors such as GA, as compared to normal 
cells (Kamal et al., 2003). This high affinity is possibly due to the environment in 
tumour cells, which makes them highly dependent on Hsp90 for proliferation (Blagg & 
Kerr, 2006). The use of Hsp90-specific inhibitors blocks the activity of multiple 
oncogenic proteins, thus preventing cancer progression. 17-AAG (tanespimycin) was 
the first Hsp90 inhibitor to enter clinical trials in 1999, followed by 17-DMAG 
(alvespimycin) in 2004. Thirteen Hsp90 inhibitors are currently undergoing clinical 
evaluation in cancer patients and 10 o f them have entered the clinics in the past three 
years (Kim et al., 2009).
1.8 Hsp90-based protein complexes in plants
The structure and functions of Hsp90 are conserved in different organisms, but the 
Hsp90 interactome and the mechanisms under its control may vary depending on the 
organism. Despite the established significance o f Hsp90 in other systems, our 
knowledge o f Hsp90 in plant cells is quite limited. Among the cytosolic AtHsp90 genes, 
AtHsp90-l is heat-inducible, and AtHsp90-2 and AtHsp90-3 are constitutively expressed 
(Yabe et al., 1994). Like mammalian Hsp90, plant Hsp90 can facilitate the folding of the 
animal glucocorticoid receptor into its mature ligand-binding conformation, suggesting
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that plant Hsp90 is functionally similar to mammalian Hsp90 (Reddy et al., 1998). 
Orthologues o f high molecular weight immunophilins [A. thaliana FK Binding Protein 
52 (AtFKBP52), AtFKBP65, AtFKBP72, AtFKBP42 or Twisted dwarf 1 (AtTWDl), 
Cyp40], AHA1, Hop, p23, PP5, Required for M la l2  resistance (RAR1), SGT1, 
Translocon o f the outer envelope o f chloroplasts (TOC64) and AtCHIP have been 
identified in plant Hsp90 complexes (Owens-Grillo et al., 1996; Stancato et al., 1996; 
Reddy et al., 1998; Berardini et al., 2001; Kamphausen et al., 2002; Takahashi et al., 
2003; Zhang et al., 2003; Ryu et al., 2005; Smyczynski et al., 2006; Azevedo et al., 
2006; Qbadou et al., 2006; Aviezer-Hagai et al., 2007; Shen et al., 2007 ; Kadota et al., 
2010). Although Hsp90 co-chaperones in plants have similar functions to their animal 
counterparts, some o f these proteins also possess unique characteristics. For example, 
the A. thaliana p23-like protein, unlike its animal counterpart, does not stabilize the 
steroid receptor-Hsp90 heterocomplex and it has no effect on the ATPase activity o f 
plant Hsp90, suggesting that its mode o f action is different from human and yeast p23 
(Zhang et al., 2010).
Our knowledge o f client proteins of Hsp90 in plants is very limited. The fact that 
inhibiting Hsp90 with RA or GA treatment in A. thaliana resulted in an array of 
morphological phenotypes (Queitsch et al., 2002), suggests that Hsp90 chaperones 
important proteins in signal transduction pathways that control plant growth and 
development. The involvement of Hsp90 in pathogen resistance pathways in A. thaliana 
(Takahashi et al., 2003; Hubert et al., 2003; Azevedo et al., 2006; Hubert et al., 2009), 
N. benthamiana (Kanzaki et al., 2003; Lu et al., 2003; Liu et al., 2004) and tomato 
(Bentem et al., 2005), supports this notion. Plant Hsp90 is involved in pathogen
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recognition through interaction with disease resistance (R) proteins and co-chaperones 
RAR1 and SGT1. Resistance to Pseudomonas syringae 1 (RPM1) as an R protein, acts 
as a receptor to recognize specific pathogen molecules and was the first client protein of 
Hsp90 to be identified in plants (Hubert et al., 2003). Therefore, it would appear that 
Hsp90 in plants also undertakes chaperoning of signalling proteins, as it does in animal 
systems.
1.9 The importance of ethylene as a phytohormone
All organisms have the ability to sense external stimuli and react in an appropriate 
manner. In this respect plants have a greater need than animals to respond fast and 
effectively to constantly changing environmental conditions due to their fixed positions. 
Phytohormones such as brassinosteroids, jasmonic acid, abscisic acid, salicylic acid and 
ethylene activate cellular responses to diverse stress situations in plants. The hormonal 
activity o f  ethylene was first discovered by Nelyubov in 1901. Ethylene is involved in 
many developmental processes, including seed germination, leaf and flower senescence, 
fruit ripening, and stress responses (Bleecker & Kende, 2000). Ethylene has a simple 
structure, which consists o f two carbons and four hydrogens (C2H4). The solubility of 
ethylene gas at 25°C is higher in organic environments than in water (Abele et al., 
1992), which means that ethylene can diffuse freely through the membrane systems 
without the need o f any carrier protein. Ethylene regulates many aspects of the plant life 
cycle including seed germination, flower development, leaf and organ senescence and 
fruit ripening. Ethylene is produced by plants under normal conditions, and is also 
induced by abiotic and biotic stresses, such as wounding, pathogen attack, and flooding, 
which in turn can lead to specific responses such as accelerated senescence, abscission
14
of infected organs, or induction o f specific defence proteins (Yoo et al., 2009). Thus, 
ethylene plays several significant roles which imply its direct effect on a plant’s ability 
for adaptation and reproduction.
1.10 Ethylene signal transduction
Ethylene is perceived by a family o f receptors that are similar to the bacterial two- 
component histidine kinase receptors. In A. thaliana, the members of subfamily I are 
ETHYLENE RESPONSE 1 (ETR1) and ETHYLENE SENSOR 1 (ERS1), while those 
o f subfamily II are ETR2, ERS2 and ETHYLENE INSENSITIVE 4 (EIN4) (Gao et al., 
2003). The subfamily I receptors have a conserved histidine kinase domain, while 
subfamily II receptors appear to function as serine/threonine kinases (Figure 3). All five 
receptors contain an N-terminal transmembrane (TM) domain followed by a cGMP 
phosho-diesterase, adenylate cyclase FhlA protein (GAF) domain, and a C-terminal 
signal output domain. The most conserved domain of these proteins is the N-terminal 
domain. This domain was found to be sufficient for saturable and reversible ethylene 
binding (Schaller & Bleecker, 1995). Some family members also have a carboxyl 
terminal receiver domain which represents the second half o f the two component 
system.
Acting downstream of the ethylene receptors is the Raf-like kinase CONSTITUTIVE 
TRIPLE RESPONSE 1 (CTR1) that functions as a negative regulator of ethylene 
signalling. According to the current model o f ethylene signalling, in the absence of 
ethylene the receptors repress ethylene responses possibly through direct activation of 
the downstream negative regulator CTRL In the presence of ethylene, CTR1 becomes 
inactivated through a conformational change induced by receptor binding to ethylene.
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Following inactivation o f CTR1, the positive regulator ETHYLENE INSENSITIVE 2 
(EIN2) activates the ethylene response pathway through downstream transcription 
factors such as EIN3 and EIN3-like proteins (EILs), which subsequently regulate other 
ethylene-responsive genes in the cascade (Lin et al., 2009). EIN3 and EILs are positive 
regulators and their protein levels are regulated by proteasome-mediated degradation via 
EIN3-Binding F-Box Protein 1 (EBF1) and EBF2, which are SKP-Cullin-F-box (SCF) 
E3 ligases (Guo & Ecker, 2003). Ethylene turns this targeted proteolysis off by 
upregulating EIN5, which in turn regulates the mRNA levels o f EBF1 and EBF2 by 
exoribonuclease activity allowing EIN3 to proceed. EIN3 is a positive regulator that 
accumulates in the nucleus and induces the expression o f the Ethylene Response Factor 
(ERF) family o f transcription factors (Yang et al., 2009). ERF1 is a positive regulator 
that binds to the ‘GCC box’ promoter element o f ethylene-regulated genes (Figure 4).
1.11 Links between Hsp90 and Ethylene
The identification o f Hsp90 client proteins is of particular interest in plants because 
plants face constant challenges from the environment, thereby requiring mechanisms 
that can promote both stability as well as flexibility in response to environmental 
conditions. Furthermore, the identification o f R proteins as clients of Hsp90 in plants 
(Hubert et al., 2003) indicates that Hsp90 regulates important signalling pathways in 
plants, which warrants identification o f additional client proteins of Hsp90. To identify 
both client proteins and co-chaperones o f Hsp90 in plants, a yeast two- hybrid (Y2H) 
screen was conducted in Dr. Krishna’s laboratory (unpublished data). Interestingly, one 
of the Hsp90 interactors identified in the Y2H screen was the ethylene receptor ERS2. 
In A. thaliana, ERS2 is located on chromosome 1 and its protein has 645 amino acids,
Figure 3: Structural features of the family o f ethylene receptors in A. thaliana. All five 
receptors contain an N-terminal transmembrane domain for ethylene binding followed by 
GAF domain which is responsible for homo and heterodimerization o f the receptors, and 
a C-terminal signal output domain. The subfamily I receptors have a conserved histidine 
kinase domain, while subfamily II receptors appear to function as serine/threonine 
kinases. Some family members also have a carboxyl terminal receiver domain (Picture 
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Figure 4: Schematic diagram of the ethylene signal transduction pathway. In the absence 
o f ethylene, receptors have direct interaction with CTR1 which in turn suppresses the 
downstream ethylene response. In the presence o f ethylene (red), CTR1 dissociates from 
the receptor and therefore EIN2 is de-repressed. Downstream of EIN2, a transcription 
factor called EIN3 promotes transcription o f ERF 1, which in turn, activates transcription 
of specific ethylene-response genes. The levels o f EIN2 and EIN3 are under the control 
o f specific F-box proteins (ETP1 and ETP2 in the case o f EIN2 and EBF1 and EBF2 in 
the case of EIN3), components of the SCF ubiquitin E3 ligase complexes that degrade 
EIN2 and EIN3 in the absence o f the ethylene gas. Another positive regulator o f the 
pathway, EIN5, an exoribonuclease, promotes mRNA decay o f the F-box genes EBF1 




with a predicted molecular mass o f 72 kDa. ERS2 is most closely related to ETR2, with 
73% amino acid similarity and it is expressed in leaves, roots, stems and flowers. ERS2 
has four transmembrane segments at the N-terminal end and it lacks the receiver domain 
(Hua et al., 1998).
The observation that the Hsp90 mutant lra2-3 is hypersensitive to the ethylene 
precursor 1-aminocyclopropane-l-carboxylic acid (ACC), relative to wild type plants, 
provided another clue towards a link between Hsp90 and ethylene signalling pathways 
(Krishna & coworkers, unpublished data). The lra2-3 has a single amino acid change 
(D80N) within the ATP-binding pocket o f Hsp90-2 (Hubert et al., 2003). As a dominant 
mutation, lra2-3 was instrumental in identifying RPM1, as a client protein of Hsp90.
Yet another link between Hsp90 and the ethylene signalling pathway comes from the 
observation that a tomato tetratricopeptide repeat (TPR) protein SITPR1, and its 
orthologue in A. thaliana (AtTPRl), were reported to interact with LeETRl (tomato 
subfamily I ethylene receptor) and ERS1 (A. thaliana subfamily I ethylene receptor), 
respectively (Lin et al., 2008; Lin et al., 2009). In our laboratory, AtTPRl and another 
TPR protein, TPR2, were identified as carboxylate clamp-type TPR proteins that were 
found to interact with Hsp90 in yeast and in vitro pull down assays, and function as 
Hsp90 co-chaperones (Prasad et al., 2010; Krishna & coworkers, unpublished data). 
Together, these observations suggest the involvement o f Hsp90 in ethylene signalling in 
A. thaliana.
EIN3 is a positive regulator o f ethylene signalling in the nucleus and it regulates a 
diverse array o f genes. EIN3 expression is tightly regulated at the protein level (Guo & 
Ecker, 2003). In animal systems, transcription factors such as steroid hormone receptors
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(Pratt et al., 2008) and B-cell lymphoma 6 (BCL-6) (Ci et al., 2009) are among the 
Hsp90 clientele. Hsp90 has a crucial role in the subcellular distribution and 
transcriptional activity o f steroid hormone receptors and in the shuttling o f BCL-6, a 
transcription factor required for development of germinal center B cells, between the 
cytoplasm and the nucleus (Ci et al., 2009). The tight regulation o f EIN3 at the protein 
level led us to hypothesise that in addition to ERS2, EIN3 may also be a client protein of 
Hsp90.
1-12 Identifying protein interactions
There are several methods to study protein interactions, two o f which are Yeast two- 
hybrid (Y2H) and Bimolecular Fluorescence Complementation (BiFC) assays. The 
GAL4-based Y2H is an in vivo system which relies on the activation of specific reporter 
genes that is mediated by the transcription factor GAL4 that regulates galactose 
metabolism, and is characterized by a DNA-binding (DB) domain, and a transcription 
activation (AD) domain (Traven et al., 2006). Y2H can be used to determine the 
interaction o f two specific proteins, or to identify unknown interactions. In Y2H system, 
all components are required to localize to the nucleus, some non-nuclear proteins may 
not fold properly in this environment. Thus, it is necessary to use a technique that 
represents the natural environment of the proteins. Similar to the Y2H system, BiFC 
involves fusion o f a gene o f interest with either an N- or C-terminal half o f a fluorescent 
protein coding sequence. When expressed, neither o f these half-fluorescent proteins are 
able to fluoresce on its own, but fluorescence is restored if  they are brought together via 
interacting fusion proteins. Since BiFC assay is dependent on fluorescence and can be 
performed in planta, the interactions can be observed in their natural environment, and
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changes in dimerization and subcellular localization can be observed in live cell without 
any fixation or staining (Kerppola, 2006).
1-13 Scope of the thesis and objectives
I hypothesise that Hsp90, at least in part, regulates the ethylene signalling pathway 
through interaction with ERS2 and possibly EIN3, and that its interaction with ERS2 
stabilises ERS2. To address this hypothesis, I have pursued the following objectives:
1) Determine the interaction o f Hsp90 with ERS2 in a targeted Y2H assay.
2) Confirm interaction of Hsp90 and ERS2 in vivo by BiFC.
3) Identify the ERS2 domain that interacts with Hsp90 by BiFC
4) Determine the stability o f ERS2 protein levels in response to RA.
5) Determine ERS2 transcript levels in response to RA.
6) Investigate whether destabilized ERS2 is degraded via the proteasome pathway.
7) Investigate the interaction o f ERS2 with TPR1 and TPR2 by BiFC.
8) Investigate localization of EIN3 and its possible interaction with Hsp90.
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Chapter Two: Materials and Methods
2.1 Plant materials and growth conditions
Seeds o f wild type (WT) and TAP-tagged ERS2 expressing transgenic A. thaliana, 
ecotype Columbia (Col-0), (kindly provided by Dr. G.E. Schaller, Dartmouth College) 
were surface-sterilized by sequentially soaking in 75% ethanol for 1 min, rinsing 3X 
with sterile water, soaking in 20% bleach for 15 min, and rinsing 5X with sterile water. 
Sterilized seeds were kept at 4°C in the dark for 3 days for vernalization. Sterilized seeds 
were planted in magenta boxes containing Murashige & Skoog (MS) basal salt mixture 
(Sigma-Aldrich) supplemented with 1% sucrose and 0.8% agar. The magenta boxes 
were placed in a growth chamber maintained at 22°C with a light intensity o f 80 pE m'
9 1s' . Seedlings were grown under 16 h light and 8 h dark conditions. N. benthamiana 
seeds were planted in soil in the green house and grown at 25°C under 16 h light and 8 h 
dark conditions and 60% humidity. For agroinfiltration, 4-5 week-old plants were used.
2.2 Plant treatments
Three-week-old seedlings o f A. thaliana were treated with either 1-aminocyclopropane- 
1-carboxylic acid (ACC), radicicol (RA) or proteasome inhibitors. A 100 mM stock 
solution o f ACC (Sigma-Aldrich) was prepared in water and filter-sterilized. The RA 
stock solution was prepared in ethanol at a concentration o f 50 mM. Stock solutions of 
the proteasome inhibitors ALLN and MG 132 were prepared in DMSO at 10 mM.
2 3  Bacterial and yeast strains and growth conditions
Bacterial and yeast strains used in this study are described in Table 1. Escherichia coli 
strain DH5a (Invitrogen Cat. No. 11319-019) was grown at 37°C in Luria-Bertani (LB) 
medium supplemented with Ampicillin (100 pg/mL) or Kanamycin (50 pg/mL).
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Agrobacterium tumefaciens strain GV3101 was grown in Yeast Extract and Beef (YEB) 
medium supplemented with Kanamycin (50 pg/mL), Rifampicin (10 pg/mL) and 
Gentamicin (25 pg/mL). For infiltration, 3 mL cultures o f A. tumefaciens were spun 
down, washed, and resuspended in a solution containing 5% D-glucose, 500 mM MES, 
1 M acetosyringone and 20 mM Na3P04-12H20.
Saccharomyces cerevisiae strains Y8800 (MATa) and Y8930 {MATa) were kindly 
provided by Dr. Jeff Dangl (Department o f Biology, University o f North Carolina) and 
grown in Yeast Extract Peptone Dextrose (YEPD) medium at 30°C overnight.
2.4 DNA constructs
The plasmids used in this study and their properties are listed in Table 2. The vector 
pDONR221 (Invitrogen) was used for subcloning PCR amplified gene fragments using 
the Gateway cloning methodology. pDONR221 is a Gateway-compatible vector 
containing a ccdB gene flanked by attP sites, which are compatible with an a//5-flanked 
PCR product. The yeast two-hybrid destination vectors pDESTDB and pDESTAD are 
Gateway-compatible vectors used for cloning the gene o f interest in frame with the 
sequence encoding either the DNA-binding (DB) domain or the transcription activation 
domain (AD) o f the GAL4 protein, respectively. These plasmids were used for 
expressing ERS2 and Hsp90 in fusion with GAL4-DB or GAL4-AD, respectively. The 
modified Gateway-compatible vectors pEarleyGate201-wTFP and pEarleyGate202- 
cYFP (Earley et al., 2006; modified by Lu et al., 2010) are used for cloning via 
recombination to express a protein o f interest in fusion with either the N- or C- terminal 
portion o f YFP, respectively. These vectors were used for expression of full length 
ERS2, Hsp90 and EIN3 in Bimolecular Fluorescence Complementation (BiFC) assays.
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Table 1: List o f  bacterial and yeast strains used in this study
Strains Properties Source
Escherichia coli DH5a ccdB-sensitive Invitrogen Cat. No. 
11319-019
DB3.1 ccdB-insensitive Invitrogen Cat. 
No.
11782-018
Agrobacterium GV3101 Gentamicin resistant, Dr. Krishna’s






















The Gateway-compatible vectors pEarleyGate 101 - YFP and pEarleyGate 104- YFP that 
contain full length YFP (Earley et al., 2006) were used for subcellular localization of 
ERS2 and EIN3. The vector p l9  was used in this study to improve the expression of 
fusion proteins by preventing transgene silencing in transient expression assays. It 
encodes a 19 kDa tomato virus protein, which is a potent suppressor o f post-translational 
gene silencing in plants (Silhavy et al., 2002; Voinnet et al., 2003).
2.5 RNA isolation and RT-PCR analysis
Total RNA was extracted from frozen leaves o f A. thaliana using SV Total RNA 
Isolation System (Promega, USA) and 1 pg o f RNA was reverse transcribed using 
Quantitect Reverse Transcription kit (Qiagen, USA). The coding sequence o f ERS2, 
available through GenBank (Accession number: AF-047976), was used to design 
primers. PCR was carried out with an initial denaturation step o f 94°C for 4 min, 
followed by 30 cycles for ERS2 and 21 cycles o f denaturation for ACTIN  (30 sec at 
94°C), annealing (30 sec at 53°C) and extension (1 min at 72°C). After the last cycle, a 
final extension was carried out for 5 min at 72°C. PCR products were visualized on 1% 
agarose gels using UV light in a Gel-Doc system (Alpha Innotech, USA).
The primers used to check the expression o f ERS2 in response to treatments o f ACC, 
RA and combination o f ACC and RA as well as ACTIN  primers used for amplification 
o f ACTIN  as an internal control are listed in Table 3.
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Table 2: List o f  plasmids used in this study
Name Properties Source
pDONR221 T7,G W,CMK,ccdB,KanK,M 13,rmBT Invitrogen 
Cat. No. 
12536-017
pEARLEY201 LB-BAR,35S,GW,CMR,ccdB,KanR,YFPN,OCS-RB ABRC stock 
No.CD3-687
pEARLEY202 LB-BAR,35S,GW,CMK,ccdB,KanR,YFPC,OCS-RB ABRC stock 
NO.CD3-688
pEARLEYlOl LB-BAR,35S,GW,CMK,ccdB,KanR,YFP,HA,OCS-RB ABRC stock 
No.CD3-683




pDESTAD G W,CMR,ccdB,AmpR,TRP 1 ,GAL4AD,ARS4/CEN6 Invitrogen,
CA
LB, left border; RB, right border; GW, gateway cassette with attRX and attRl 
recombination sites; 35S and T, cauliflower mosaic virus 35 S promoter and terminator; 
AmpR, Ampicillin resistance; CmR, chloramphenicol resistance; Kan R, Kanamycin 
resistance; GenR, Gentamicin resistance; ccdB, ccdB gene for negative selection; 
CYH2S, Cycloheximide sensitive; GAL4AD, GAL4 activation domain; GAL4DB, 
GAL4 DNA binding domain; OCS, the 3' sequence o f the octopine synthase gene, 
including polyadenylation and transcription termination sequences; YFPN, N-terminus 
of YFP ; YFPC, C-terminus of YFP; LEU2, for selection in yeast on medium lacking 
leucine; TRP1, for selection in yeast on medium lacking tryptophan; ARS4/CEN6, for 
replication and maintenance at low-copy number in yeast.
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Table 3: List o f  primers used in this study







ERS2-F GGGG ACA AGT TTG TAC AAA AAA 
GCA GGC TCC
AT GTT AAAG AC ATT GTT AGTCC AAT GGC
59
ERS2-R GGG GAC CAC TTT GTA CAA GAA AGC 
TGG GTC
GT GGCT AGTAGACGG AGG AGTT G
53
EIN3-F GGGG ACA AGT TTG TAC AAA AAA 
GCA GGC TCC ATG ATG TTT AAT GAG 
ATG GGA ATG
55
EIN3-R GGG GAC CAC TTT GTA CAA GAA AGC 









CTR1-R GGG GAC CAC TTT GTA CAA GAA AGC 
TGG GTC CAAATCCGAGCGGTTGG
46
Hsp90-2-F GGGG ACA AGT TTG TAC AAA AAA 
GCA GGC TCC ATGGCG GAC GCT GAA 
ACC TTT GCT TTC
57
Hsp90-2-R GGG GAC CAC TTT GTA CAA GAA 
AGCTGG GTC GTC GAC TTC CTC CAT 




GGG GAC CAC TTT GTA CAA GAA AGC 





GGG GAC CAC TTT GTA CAA GAA AGC 




GGG GAC CAC TTT GTA CAA GAA AGC 




2.6 Detection of proteins by western blotting
Total cellular proteins were isolated as described by Dhaubhadel et al., (1999) with 
minor modifications. Total cellular proteins from leaves of WT and transgenic A. 
thaliana were isolated in a buffer containing 50 mM Tris pH 8, 1% SDS, 1 mM EDTA 
and protease inhibitor cocktail (Sigma, Cat. No. P9599). Protein concentration was 
determined using a Bio-Rad Protein Assay system. Proteins (20 pg) were separated on 
7.5% (w/v) SDS-polyacrylamide gels and transferred onto nitrocellulose membranes by 
electroblotting using a Trans-Blot Semi-Dry Electrophoretic Transfer Cell (Bio-Rad). 
TAP-tagged ERS2 was detected using an anti-TAP antibody (Thermo Scientific Cat. 
No. CAB 1001) at a dilution o f 1: 5000 (v/v). The peroxidase-conjugated anti-rabbit IgG 
(Promega Cat. No. W401B26824903) was used at a dilution o f 1: 5000 (v/v). Anti- 
ubiquitin or anti-P tubulin primary antibodies were used to detect ubiquitin and P tubulin 
as loading controls. The antigen-antibody complexes were detected using the enhanced 
chemiluminescence detection system (ECL system, Amersham Biosciences).
2.7 Cloning procedures
2.7.1 Primer design
For Gateway cloning, all forward primers incorporate a 5'attBl site, while reverse 
primers incorporate a 3 'attB2 site. All primers were designed and analyzed using 
DNAMAN software (Lynnon BioSoft, version 6.0), and were purchased from Eurofins.
2.7.2 PCR amplification
T W
PCR amplification o f all gene fragments was performed using My cycler BioRad 
thermo cycler. cDNA o f interest was made as described in section 2.5 and used as
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template DNA. Appropriate annealing temperatures were determined for amplification 
of each fragment and primer combination.
2.7.3 Agarose gel electrophoresis
DNA fragments were separated on 1% agarose gels (w/v) prepared in IX TBE buffer. 
Ethidium bromide (1.5 pg/mL) was added to agarose prior to solidification. For excising 
gene fragments from the gel for the purpose o f cloning, ethidium bromide was used to 
stain the ladder and 5 ul PCR products o f the fragment to be recovered rather than 
adding it to the gel prior to solidification. DNA samples were loaded in the presence of 
IX DNA loading dye and gels were electrophoresed at 110 V. DNA bands were 
visualized using UV light in a Gel-Doc system.
2.7.4 Agarose gel purification of DNA fragments
DNA fragments were excised from gels and recovered using the E.Z.NA gel extraction 
kit as per manufacturer’s instruction.
2.7.5 Gateway cloning strategy
The Gateway cloning technology takes advantage o f site-specific recombination to 
move a gene of interest into multiple vector systems with high efficiency. This method 
eliminates the need for conventional DNA ligase-mediated molecular cloning. Purified 
PCR products were subcloned into the vector pDONR221 via recombination between 
the attB sites flanking the PCR product and attP sites on pDONR221 through BP 
reaction (Invitrogen), which resulted in the creation o f entry clones. The insert was then 
transferred into the destination vector via recombination between the attL sites flanking 
the insert and attR sites on the destination vector through LR reaction (Invitrogen). Both 
pDONR221 and the destination vectors contain a ccdB gene that is lethal to most strains
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of E. coli. Therefore, empty destination vectors are selected negatively. This negative 
selection combined with positive selection for an antibiotic resistance marker, ensures 
that resulting colonies contain plasmids that have undergone recombination. However, 
before the LR recombination reaction, a linearization reaction is necessary among entry 
clones and destination vectors because both entry clones and destination vectors contain 
the same antibiotic (Kanamycin) resistance gene. Once the entry clones are linearized, 
only true positive colonies containing the insert can survive. Details o f each gene cloned 
via Gateway cloning technique in this study are explained in related sections.
2.7.6 Plasmid DNA isolation
The small-scale plasmid preparations from bacterial cultures were performed using the 
QIAprep Spin Mini prep Kit (QIAgen, Cat. 27104), following the manufacturer’s 
instruction.
2.7.7 DNA sequencing
The constructs made in this study were confirmed by DNA sequencing carried out with 
an automated sequencer at the DNA Sequencing Facility, Robarts Research Institute, 
London, ON, Canada.
2.7.8 Computer analysis
DNA sequence analysis and primer design were carried out using DNAMAN software 
(Lynnon BioSoft, version 6.0, Canada).
2.8 Transformation procedures
2.8.1 Preparation of Agrobacterium  competent cells
A single colony o f A. tumefaciens strain GV3101 was inoculated in 3 mL of LB media 
supplemented with Gentamicin (25 pg/mL) and Rifampicin (10 pg/mL) in a 15 mL
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falcon tube and grown overnight at 30°C in a shaker incubator. LB medium (100 mL) 
was inoculated with 0.5 mL of the overnight culture and grown at 30°C with vigorous 
shaking until mid-log phase of growth (OD 600 of 0.5-1.0). After several washes in ice- 
cold 10% glycerol, tubes were quick-frozen in liquid nitrogen and stored at -80°C.
2.8.2 Preparation of yeast competent cells
TE/LiAc (100 mM LiAc, 100 mM Tris pH 8.0 and 10 mM EDTA) and TE/LiAc/PEG 
solutions [40% (w/v) PEG4000 (polyethylene glycol 4000, Sigma), 100 mM LiAc, 100 
mM Tris pH 8.0, 10 mM EDTA] were prepared in advance. The appropriate yeast strain 
was scraped from a frozen glycerol stock, transferred to YEPD medium (10 g/L yeast 
extract, 20 g/L peptone, 20 g/L glucose, pH 6.0) and grown overnight (about 18 h) at 
30°C in a shaking incubator. YEPD media (10 mL) was inoculated with an overnight 
culture (OD600 o f 0.1) and grown at 30°C for 4 h to an OD of 0.3-0.5. The yeast culture 
was then centrifuged at 400 xg  for 5 min and resuspended in 4 mL sterile water. 
Centrifugation was repeated twice and the pellet was resuspended in TE/ LiAc solution 
in a total volume o f 1 mL.
2.8.3 Bacterial transformation
T W
The E. coli competent cells [Subcloning Efficiency DH5a Competent Cells, 
Invitrogen (Cat. No. 18265-017)] were thawed on ice. Approximately 1-10 ng DNA 
from LR reaction was added to 30 pi o f the competent cells. The tubes were then 
incubated on ice for 30 min, heat shocked in a 42°C water bath for 30 sec, and 
immediately placed back on ice for 2 min, then 250 pi of LB medium was added to the 
cells. Tubes were incubated at 37°C for 1 h at 225 rpm before being spread onto LB
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plates containing 50 pg/mL Kanamycin. The plates were incubated overnight in an 
inverted position in a 37°C incubator to allow the transformed cells to form colonies.
For A. tumefaciens transformation, competent cells were thawed on ice and mixed with 
100 ng transforming DNA containing the desired insert using a Gene Pulser II System 
(Bio-Rad) with the following settings: 2 kV, 400 G, 25 pF. Transformed cells were 
allowed to recover for 2 h in LB medium at 30°C before plating on LB plates 
supplemented with appropriate antibiotics.
2.8.4 Yeast transformation
Salmon sperm DNA (10 pg/pl) was bought from Invitrogen (Cat. No.15632-011). To 20 
ul o f yeast competent cells, 2 pi o f Salmon sperm DNA, 0.5 pg o f plasmid DNA and 
100 pi o f TE/LiAc/PEG solution [40% (w/v) PEG4000, 100 mM LiAc, 100 mM Tris 
pH 8.0, 10 mM EDTA] were added and the cells were incubated at 30°C for 30 min and 
then at 42°C in a water bath for 15 min. The yeast cells were then centrifuged at 400 xg  
for 5 min. The supernatant was removed and the transformed cells were suspended in 
100 pi o f sterile water and plated onto the appropriate selection medium.
2.9 Preparation of constructs for yeast two-hybrid assay
To determine the interaction of ERS2 with Hsp90-2 and CTR1 by the yeast two-hybrid 
approach, Hsp90-2 and CTRl coding sequences were cloned into the bait vector 
separately while ERS2 was cloned into the prey vector. Hsp90-2 was amplified by PCR 
using the cDNA clone C l05057 (Arabidopsis Biological Resource Center). The PCR 
product was cloned into pDONR221 by in vitro BP recombination to generate 
pDONRHsp90-2, which was used in LR reaction with pDestDB (bait vector) to generate 
pDBHsp90-2. The aforementioned construct was prepared by Dr. Bishun Prasad. ERS2
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and CTR1 cDNAs were synthesized from total RNA isolated from A. thaliana leaf tissue 
using gene-specific Gateway reverse primers and Quantitect Reverse Transcription kit 
(Qiagen, USA). CTR1 cDNA was made and cloned into pDONR221by Jason Lehrer. 
CTR1 was cloned, as described for Hsp90-2, into pDestDB to generate pDBCTRl. 
ERS2 PCR product was cloned into pDONR221 by in vitro BP recombination to 
generate pDONRERS2, which was used in LR reaction with pDestAD to generate 
pADERS2 (prey vector). All primers used for the mentioned reactions are listed in Table 
3.
2.10 Plasmid construction for Bimolecular Fluorescence Complementation assay 
The clones used in this project were constructed using the Gateway technology. Primers 
were designed according to the Gateway primer design protocol using the ERS2 and 
EIN3 coding sequences available through GenBank (Accession numbers: AF-047976 
and AF-004216, respectively). The entire ERS2 and EIN3 coding sequences were 
amplified using Phusion™ High-Fidelity DNA Polymerase (New England Biolabs), 
cDNAs prepared using RNA isolated from A. thaliana WT (Col-0).
The amplified products were cloned into pDONR221 and sequenced to check the 
integrity o f the fragments.
To prepare ERS2- and EIN3- cYFP and -nYFP fusions, pDONRERS2 and pDONREIN3 
(without any stop codon) were separately transferred into the modified Gateway binary 
vectors p201 and p202 (Earley et al., 2006; modified by Lu et al., 2010) by LR 
recombination reaction to produce p201 -ERS2-nYFP, p20\-EIN3-nYFP, p202-ERS2-
cYFP and p202-EIN3-cYFP.
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For subcellular localization o f ERS2 and EIN3 proteins, pDONRERS2 and 
pDONREIN3 (without any stop codon) were separately cloned in pEarly Gate 101 and 
pEarley Gate 104 vectors (Earley et al., 2006), by LR recombination reaction to generate 
pl01-£/?S2-full length YFP, pl04-£/?S2-full length YFP, pl01-£/AG-full length YFP 
and pl04-£YAG-full length YFP. Following sequence verification after the LR reaction, 
all constructs were transformed into the A. tumefaciens GV3101 by electroporation and 
plated on LB media supplemented with Kanamycin (50 pg/mL). A 50% glycerol stock 
from each colony was made and stored at -80°C.
To determine which region o f ERS2 is involved in binding Hsp90, a series o f truncated 
ERS2 fusions were made and tested for interaction with Hsp90 in BiFC assay. Primers 
mentioned in Table 3 were used in making deletion constructs in pDONR by BP 
reaction and subsequently moved into the destination vector by LR reaction. Truncated 
versions carry 1-358 amino acids, lacking the entire histidine kinase domain, 1-462 
amino acids lacking the four of the five consensus motifs essential for the auto-kinase 
activity o f bacterial histidine kinase,
and 1-562 amino acids lacking small part of the histidine kinase domain but retaining 
the above-mentioned essential amino acids in the N-box. A schematic diagram of ERS2 
truncated versions are shown in Figure 5.
Constructs for p201 -Hsp90-2-nYFP and p202-Hsp90-2-cYFP, p20\-TPRl-nYFP  and 
p202-TPRl-cYFP, p20\-TPR2-nYFP and p202-TPR2-cYFP, and p20\-Dwarf!-nYFP 
and p202-Dwarfl-cYFP were made by Dr. Bishun Prasad.
Figure 5: Schematic diagram of the truncated versions of ERS2 protein. The consensus 
motifs (H, N and G l) found in bacterial histidine kinases are indicated in the schematic of 
the ERS2 kinase domain. (TM: transmembrane domain, GAF: cGMP phosho-diesterase, 
adenylate cyclase FhlA protein domain, HK: histidine kinase domain. Numbers represent 
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38
2.11 Yeast two-hybrid assay
After all constructs were verified by sequencing, pDBHsp90-2 and pDBCTRl were 
transformed into Y8930, and pADERS2 was transformed intoY8800 yeast strains. 
Following selection of transformants on synthetic complete (SC) media lacking either 
leucine (bait vector) or tryptophan (prey vector), bait and prey transformants were 
mated and selected on SC media lacking leucine and tryptophan (27 g/L Drop Out Base 
medium (DOB), 1.5 g/L -Trp -Leu dropout mixture, 20 g/L glucose pH 5.8). The 
interaction o f pDBHsp90-2 and pDBCTRl with pADERS2 was determined based on 
the HIS reporter assay and the ability to grow on SC -Leu -Trp -H is (27 g/L Drop Out 
Base (DOB), 1.4 g/L -L eu -Trp -H is dropout mixture, 20 g/L glucose pH 5.8) plus 3 
mM 3-aminotriazole (3AT) (Sigma- Aldrich, Germany), which is an inhibitor of the 
dehydratase encoded by the HIS gene. The transformed yeast was picked from the 
master plate, suspended in 30 pi of water and 5pi was spotted on selective plates. The 
plates were incubated at 30°C for 7 days.
2.12 Introduction of plasmid DNA into plant tissue
Transformed A. tumefaciens were infiltrated into epidermal N. benthamiana cells for 
transient expression as described by Sparkes et al., (2006). After infiltrating into the 
lower leaf epithelium of N. benthamiana, plants were kept in the greenhouse for 3 days 
when fluorescence was evaluated by confocal microscopy.
2.13 Fluorescence microscopy
Imaging o f YFP fluorescence in tobacco leaf was conducted under a laser scanning 
confocal microscope (Zeiss LSM510). The excitation wavelength used for YFP was 514 
nm, and the emission filter wavelength was 520-550 nm. For visualization, tobacco leaf
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pieces were directly mounted on glass slides in a drop of water. For each experiment, at 
least three different samples were examined under the laser scanning microscope. 
Individual cells were observed with either a 20X or 40X objectives. Data for the 
different color channels were collected simultaneously.
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Chapter Three: Results
3.1 ERS2 interacts with Hsp90 and CTR1 in yeast two-hybrid assay
To identify interactors of Hsp90 in plants, a yeast two-hybrid (Y2H) screen was carried 
out using Brassica napus Hsp90 cDNA (Krishna et al., 1995) as ‘bait’ against a 
Brassica napus pistil cDNA library (Silva et al., 2001). Two partial cDNAs encoding an 
orthologue of ERS2, a member o f the A. thaliana ethylene receptor family, were 
isolated, among others, as positive interaction clones (Krishna et al., unpublished data). 
To confirm the interaction of ERS2 with Hsp90 and to test the possible interaction of 
ERS2 with CTR1, a targeted Y2H assay was performed. Yeast cells carrying 
pDBHsp90, pDBCTRl and pADERS2 were mated with a corresponding empty vector. 
We tested all three fusion proteins for self-activation in the absence of any interaction. 
None of the three fusion proteins showed self-activation of the reporter gene (Figure 6, 
lower panel). The interactions between ERS2 as prey and Hsp90 or CTR1 fusion protein 
as bait, led to the activation o f the reporter gene HIS3, allowing transformants to grow 
on the dropout agar medium (-Leu -T rp -His) plus 3 mM 3AT (Figure 6). The 
interaction between CTR1-ERS2 and Hsp90-ERS2 was strong enough to form colonies 
on a plate with 3 mM 3AT; the negative controls by comparison did not show any 
growth at this concentration (Figure 6).
3.2 ERS2 physically interacts with Hsp90 in planta
To confirm interaction between ERS2 and Hsp90 in planta, we used Bimolecular 
fluorescence complementation (BiFC) assay. Since this system relies on reconstitution 
of fluorescence rather than transcriptional activation of reporter genes, it allows for 
detection of protein interaction, as well as determining the subcellular localization of the
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interaction. To test if  half YFP proteins are able to dimerize in the absence of any 
interacting proteins, empty vectors carrying N- or C-terminal YFP as well as Hsp90- 
cYFP and empty vector-nYFP were introduced into tobacco leaves (Figure 7, left 
panels). A complete set o f controls for all BiFC experiments are shown in 
Supplementary Figure 1. A construct expressing full-length YFP (pEarleyGatel04- 
YFP), which is known to localize to the cytoplasm and nucleus, was used as a positive 
control (Figure 7, upper right).
Since Hsp90 functions as a dimer, the ability of AtHsp90-2 (hereafter referred to as 
Hsp90) to dimerize in plant a was studied by co-infiltrating Hsp90-cYFP with Hsp90- 
nYFP. A strong YFP fluorescence signal was detected in the cytoplasm with this 
combination of constructs, indicating that Hsp90 forms a dimer in plant cells (Figure 7, 
lower right).
A strong fluorescence signal was also observed for the fusions ERS2-full-length YFP 
and full-length YFP-ERS2 that were infiltrated individually into tobacco leaves (result 
was shown only for ERS2-full-length YFP in Figure 8, upper panel).
To address if ERS2 interacts with Hsp90 in planta, ERS2-cYFP and Hsp90-nYFP, and 
ERS2-nYFP and Hsp90-cYFP constructs were co-introduced in tobacco leaves together 
with p i9 plasmid. A clear YFP fluorescence signal was observed with both 
combinations of ERS2 and Hsp90 fusion proteins in the presence of p i9, but not with 
controls, indicating that these two proteins can physically associate in planta (Figure 8, 
lower panels). As controls, each fusion construct was co-infiltrated with p i9, but not 
with the fusion containing the corresponding half of YFP. No fluorescence was detected 
in the absence of a corresponding half-YFP construct (Supplementary Figure 1).
Figure 6: The interaction of ERS2 with full-length Hsp90 and CTR1 in Y2H. Positive 
interaction between Hsp90 and ERS2 in yeast, resulting in the activation of reporter 
genes, was detected by growth on SC -Leu -T rp -H is + 3 mM 3AT (lower panel). No 
growth on this medium was observed for plasmid combinations in the absence o f either 
Hsp90 or ERS2. Yeast cells were grown on SC -  Leu -Trp to select for both pDB and 





Figure 7: Positive and negative controls for BiFC assay. Representative images from 
confocal laser scanning microscopy showing chlorophyll autofluorescence (upper left), 
reconstituted YFP fluorescence (upper right), bright field (lower left) and the overlay of 
all three channels (lower right) in leaf epidermal cells of 3-week-old soil grown tobacco, 
72 h after individual infiltration with Agrobacterium harbouring either empty vector- 
nYFP and empty vector-cYFP or Hsp90-cYFP and empty vector-«YFP as negative 
controls (left panels); empty vector -full length YFP or Hsp90-nYFP+Hsp90-cYFP as 
positive controls (right panels). As expected, no fluorescence signal was detected for 
negative controls. The scale bar is 20 pm.
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Figure 8: BiFC visualization of ERS2 association with Hsp90. Representative images 
from confocal laser scanning microscopy of tobacco leaves infiltrated with ERS2-full 
length YFP (upper left), or co-infiltrated with ERS2-nYFP and Hsp90-cYFP together 
(lower left), and ERS2-cYFP and Hsp90-nYFP together (lower right). To enhance 
expression o f the fusion constructs, p i9 was included for co-infiltration of ERS2 and 
Hsp90 fused to half YFP. Images were taken 72 h after infiltration with Agrobacterium. 
A close up image from YFP channel was included indicating ERS2 distribution pattern in 




3.3 Treatment with radicicol decreases the steady state levels of ERS2 protein
Since the prior experiments displayed the interaction of Hsp90 with ERS2 in both Y2H 
and BiFC assays, we then evaluated the effect of Hsp90 inhibition on the stability of the 
ERS2 protein levels in TAP-tagged ERS2 transgenic A. thaliana seedlings to determine 
if ERS2 is degraded due to Hsp90 inhibition in a time course experiment, implying it is 
a client protein. Since ERS2 is not an abundant protein, prior to inhibition of Hsp90 by 
RA, leaves were treated with ACC (50pM), a precursor of ethylene biosynthesis, for 4h 
to elevate ERS2 levels. The 4 h treatment of leaves with ACC was predetermined in a 
time course experiment aimed at increasing the levels of tagged ERS2. A clear cut 
reduction in the levels o f TAP-tagged ERS2 was observed at 6 and 12 h of RA 
treatment, while no reduction was seen in control leaves (Figure 9).
3.4 ACC increases, while RA decreases, ERS2  transcript levels
A decline in the steady state levels of proteins may occur due to alteration in either the 
rate o f their synthesis or degradation or both. To determine if  ERS2 transcript levels are 
affected by RA and ACC, individually or combined together, leaves of TAP-tagged 
ERS2 A. thaliana plants were subjected to treatment for the indicated times and ERS2 
transcript levels were analysed using RT-PCR. Primers were designed to pick up both 
endogenous and TAP-tagged ERS2. ACTIN  was used as an internal control. In response 
to ACC, as would be expected, ERS2 transcript levels increased in a time-dependent 
manner and were higher than in untreated leaves at 2 and 6 h, whereas in response to RA 
the mRNA levels declined early on and then remained constant over the time period of 
the experiment. In response to ACC and RA together, the overall effect was an increase
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in the levels at 2 and 6 h, but this increase was less than that seen with ACC alone 
(Figure 10).
3.5 RA mediates disruption of Hsp90-ERS2 interaction in planta
Figure 9 demonstrates that treatment with RA decreased the steady state levels of TAP- 
tagged ERS2. To see if this effect arose from disruption of Hsp90 interaction with TAP- 
tagged ERS2 by RA, we studied the effect of RA on protein interaction in BiFC assay. 
ERS2-cYFP or ERS2-nYFP was co-infiltrated with Hsp90-nYFP or Hsp90-cYFP, 
respectively into tobacco leaves. After 72 h, leaves were treated with RA and visualized 
at the end o f each time point to see if the interaction between ERS2 and Hsp90 falls 
apart due to Hsp90 inhibition. Indeed, the fluorescence intensity derived from 
bimolecular fluorescence complementation of Hsp90-ERS2 interaction was reduced by 
1 h of RA treatment as compared to 1 h control, and nearly abolished by 6 h of treatment 
(Figure 11). Although similar results were obtained using both combinations ERS2- 
nYFP+Hsp90-cYFP and ERS2-cYFP+Hsp90-nYFP, the results are only shown for one 
combination {ERS2-n YFP+Hsp90-cYFP).
3.6 The effect of RA on Hsp90-ERS2 interaction is specific
To determine if  the effect of RA leading to the disappearance of the fluorescence signal 
derived from Hsp90-ERS2 association is specific to this protein set, we tested the effect 
of RA on dimerization of Dwarfl. Dwarfl is involved in the conversion of 24- 
methylenecholesterol to campesterol in the brassinosteroid biosynthesis pathway (Choe 
et al., 1999). Since Dwarfl protein acts as a dimer (Krishna et al., unpublished data), it 
was expected that a YFP signal would be generated by dimerization, as in the case of 
Hsp90 (Figure 7). To achieve this goal, Dwarfl-nYFP  was co-infiltrated with Dwarfl-
Figure 9: Western blot analysis indicating TAP-tagged ERS2 protein levels in response 
to RA treatment. Leaves o f 21-day old TAP-tagged ERS2 A. thaliana seedlings were pre­
treated with 50 pM ACC (precursor of ethylene biosynthesis) for 4 h and then subjected 
to 50 pM RA (inhibitor of Hsp90) treatment. Controls were floated in MS medium 
supplemented with 0.1% ethanol (solvent of RA). Protein levels o f TAP-tagged ERS2 
were detected using anti-TAP antibody. J3 tubulin was used as a loading control. The 
Coomassie blue staining indicates Rubisco band in the lower panel. Numbers represent 
relative levels of ERS2 being normalized relative to the loading control.
6 h 12 h
Anti-p tubulin
1.0 3.6 1.0 2.2 1.1 4.9
Rubisco
Figure 10: RT-PCR analysis of ERS2 transcript levels in response to ACC and RA. ERS2 
transcript expression was monitored at indicated times after addition o f 50 pM RA, 50 
pM ACC, and 50 pM each of ACC+RA. ACTIN  RNA expression levels were used as 
loading control.
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cYFP into tobacco leaves and treated with RA as described in section 3.5, for the 
indicated time points. Interestingly, the fluorescence signal generated by Dwarfl 
dimerization for the most part remained unaffected up to 6 h of incubation with RA 
(Figure 12, right panels).
3.7 The RA effect on TAP-tagged ERS2 levels arises in part from proteasome- 
mediated degradation
It is well established in literature that disruption of Hsp90-client protein interaction by 
Hsp90 inhibitors leads to the degradation of the client protein by the 26S proteasome 
pathway (Trepel et al., 2010). Although RA reduced the levels of TAP-tagged ERS2 
(Figure 9), it was unclear if this was due to protein degradation. To investigate whether 
ERS2 is degraded by the proteasome in response to RA, we used two proteasome 
inhibitors: MG132 and ALLN. TAP-tagged ERS2 A. thaliana leaves were pre-treated 
with 50 pM ACC for 4 h and then incubated with RA (50 pM) alone or combined with 
MG132 and ALLN (50 pM) separately for indicated time points, followed by western 
blot analysis o f TAP-tagged ERS2 levels. Both MG132 and ALLN counteracted the RA 
effect o f down-regulating the steady state levels of TAP-tagged ERS2 within the first 30 
min, but not at 1 and 2 h time points (Figure 13).
3.8 RA induces proteasome-dependent degradation of ERS2 in planta
We corroborated our results o f western blot analysis (Figure 13) involving RA and 
proteasome inhibitors using BiFC. If the disappearance of the fluorescence signal based 
on Hsp90-ERS2 interaction, was due to the turnover of ERS2-YFP in response to RA, 
inclusion of proteasome inhibitors should maintain the fluorescence signal. To address 
this, 72 h after co-infiltration of N. benthamiana leaves with ERS2-nYFP+Hsp90-cYFP
Figure 11: BiFC visualization of Hsp90-ERS2 interaction following treatment with RA. 
Leaves of N. benthamiana co-infiltrated with ERS2-nYFP and Hsp90-cYFP together with 
p i9 and then floated in MS medium supplemented with 0.1% ethanol (control, left 
panels) and 50 pM RA (right panels) and visualized with laser confocal microscopy after 
indicated time points. The scale bar is 50 pm.
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Figure 12: BiFC visualization o f Dwarfl dimerization following treatment with RA. 
Leaves o f N. benthamiana co-infiltrated with Dwarfl-nYFP  and Dwarfl-cYFP  and then 
floated in MS medium supplemented with 0.1% ethanol (control, left panels) and 50 pM 
RA (right panels) for 1 ,2  and 6 h and visualized with laser confocal microscopy after 





and ERS2-cYFP+Hsp90-nYFP, the infiltrated leaves were treated with RA and 
proteasome inhibitors as described in section 3.7 and the epidermal cells were visualized 
by confocal microscopy. As observed before in Figure 11, RA reduced the fluorescence 
signal in a time dependent manner (Figure 14), but in the presence of proteasome 
inhibitors the fluorescence intensity was even slightly higher than in controls within the 
first 30 min. Although the fluorescence signal declined at 1 and 2 h of treatment, it was 
not completely abolished.
3.9 ERS2 interacts with Hsp90 through its C-terminal kinase domain
To determine which region of ERS2 is involved in binding Hsp90, a series of truncated 
versions within the kinase domain of ERS2 protein were made and tested for interaction 
with Hsp90 in BiFC assay. Since ERS2 is a membrane localized protein kinase, the TM 
and GAF domains were kept intact in all fusions for proper subcellular localization. 
Schematic diagram of the truncated versions of ERS2 protein are shown in Figure 5. All 
versions o f truncated ERS2 fused to full-length YFP were expressed (Figure 15, left 
panels). When tested for interaction with Hsp90 in BiFC, the ERS2A563-645 that had 
part of the kinase domain with N and G1 boxes was able to interact with Hsp90 (Figure 
15, top right), but further deletion of the kinase domain from the C-terminal end in 
ERS2A463-645-nYFP, and the deletion o f the entire kinase domain in ERS2A359-645- 
nYFP, abolished the interaction with Hsp90 (Figure 15, middle and lower right panels). 
Results are shown only for ERS2A359-(A5-nYFP, ERS2A463-645-nYFP and 
ERS2A563-645-nYFP with Hsp90-cYFP (Figure 15).
3.10 ERS2 interacts with Hsp90 co-chaperones TPR1 and TPR2 in planta
Since Hsp90 co-chaperones interact with Hsp90 and also with Hsp90 client proteins, we
Figure 13: RA inhibition of Hsp90 induces proteasomal degradation o f TAP-tagged 
ERS2. Leaves of 21-day old TAP-tagged ERS2 A. thaliana seedlings were pre-treated 
with ACC (precursor o f ethylene biosynthesis) for 4 h and then subjected to RA treatment 
with or without proteasome inhibitors (ALLN and MG132) for 0.5, 1 and 2 h and 
analysed by western blotting to detect TAP-tagged ERS2 levels using anti-TAP antibody. 
Ubiquitin was used as a loading control. Numbers represent relative levels o f ERS2 being 




Figure 14: ERS2 turnover in planta is proteasome-dependent. Representative images 
from co-infiltration of ERS2-nYFP and Hsp90-cYFP into N. benthamiana leaf epidermal 
cells. Leaves were treated with or without 50 pM RA, or 50 pM RA plus MG132 or 
ALLN for 30 min, 1 h and 2 h and visualized with laser confocal microscopy to detect the 
intensity of the fluorescing signal resulting from each treatment. To enhance expression 








investigated the interaction of ERS2 with two TPR proteins, TPR1 and TPR2, which 
were found to interact with Hsp90 in Y2H and in vitro pull down assays, as well as to 
function as Hsp90 co-chaperones (Prasad et al., 2010; Krishna & coworkers, 
unpublished data). To achieve this goal, ERS2-cYFP was co-infiltrated with TPRl-nYFP 
and TPR2-nYFP, and ERS2-nYFP was co-infiltrated with TPRl-cYFP and TPR2-cYFP 
into leaf epidermal cells of N. benthamiana. Prior to co-infiltration, each construct was 
infiltrated individually to ensure that it was not able to fluoresce in the absence of a 
corresponding half-YFP construct (Supplementary Figure 1). None of the constructs 
were able to fluoresce on their own, but fluorescence was generated as a result of 
interaction between ERS2 and TPR1, as well as ERS2 and TPR2 (Figurel6). 
Interestingly, ERS2 was able to interact with TPR2 in both combinations but in the case 
of TPR1 only with TPRl-nYFP.
3.11 EIN3 interacts with Hsp90 in the nucleus
To investigate whether Hsp90 associates with EIN3, a downstream component of the 
ethylene signalling pathway in the nucleus, Hsp90-nYFP or Hsp90-cYFP, were co- 
infiltrated with EIN3-cYFP or EIN3-nYFP, respectively. Since EIN3 is a transcription 
factor, it localises to the nucleus (Guo & Ecker, 2003). In our study, in accordance with 
its known subcellular localization, EIN3-full-length YFP localized to the nucleus (Figure 
17, upper panel). Prior to co-infiltration, each construct was infiltrated individually to 
ensure that it was not able to fluoresce in the absence of a corresponding half-YFP 
construct. None of the constructs were able to fluoresce on their own (Supplementary 
Figure 1). As shown in Figure 17, Hsp90 interacts with EIN3 in the nucleus which
matches with the subcellular localization o f EIN3.
Figure 15: BiFC visualization of Hsp90 interaction with truncated versions of ERS2. 
Leaves of N. benthamiana co-infiltrated with truncated versions ERS2A359-645-nYFP 
(lower right panel), ERS2A463-645-nYFP (middle right panel) and ERS2A563-645-nYFP 
(upper right panel) with Hsp90-cYFP. Corresponding truncated ERS2 versions fused to 
full-length YFP are all expressed (left panels). To enhance expression o f the fusion 
constructs, p i9 was included in all infiltrations. Images were taken 72 h after co- 
infiltration and visualized by confocal microscopy. The scale bar is 50 pm.
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Figure 16: BiFC visualization of ERS2 interaction with TPR1 and TPR2. Confocal 
images were taken 72 h after co-infiltration from N. benthamiana epidermal cells co­
expressing ERS2-nYFP and TPR2-cYFP (top row), ERS2-cYFP and TPR2-nYFP (middle 
row), and ERS2-cYFP and TPRl-nYFP  (bottom row). To enhance expression o f the 
fusion constructs, pi 9 was included in all infiltrations. The scale bar is 20 pm.
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Figure 17: Hsp90 interacts with EIN3 in planta. Confocal images from N. benthamiana 
epidermal cells expressing E1N3-full-length YFP (upper panel), and EIN3-nYFP+Hsp90- 
cYFP (lower panel). Plasmid p i9 was added to improve the interaction of EIN3- 
nYFP+Hsp90-cYFP. Pictures were taken 72 h after co-infiltration. Close up images 
indicating subcellular localization of EIN3 as well as EIN3-Hsp90 interaction in YFP 
field are included. The scale bar is 10 pm.
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Hsp90 is at the core of a nexus of functional interactions with proteins involved in signal 
transduction and transcriptional regulation pathways. The majority of proteins identified 
as Hsp90 clients are through studies in animal systems (Trepel et al., 2010) in which 
kinases and transcription factors form the largest Hsp90 clientele (Pearl et al., 2008). To 
date, only the disease resistance (R) proteins have been identified as client proteins of 
Hsp90 in plants, indicating that the functions of plant Hsp90 are also linked with 
signalling pathways (Shirasu, 2009).
In this study, we present evidence for ERS2, a membrane-bound receptor of the plant 
hormone ethylene, as a new client protein o f plant Hsp90. ERS2 belongs to the 
subfamily II whose members lack conserved residues believed to be important for 
histidine kinase activity (Moussatche & Klee, 2004). Most studies on ethylene receptors 
have been carried out using ETR1, which has the ability to heterodimerize with other 
family members, including ERS2 (Gao et al., 2008; Gerfen et al., 2008). The 
interactions between different ethylene receptors are believed to contribute to the 
ethylene signal output. The component immediately downstream to ethylene receptors is 
CTR1, which is known to interact with the receptors via their kinase domain (Gao et al., 
2003; Qu & Schaller, 2004; Bisson & Groth, 2010).
4.2 Hsp90 interacts with ERS2 in yeast cells and in planta
The interaction of Hsp90 with ERS2 was consistently detected by the two approaches 
used in the present study; yeast two-hybrid (Y2H) and Bimolecular Fluorescence 
Complementation (BiFC) assays. The Y2H assay is a powerful technique for observing
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physical interaction between two proteins in vivo, both for identifying potential binding 
partners o f the protein of interest as well as for further characterization of known 
interactions. Although ERS2 was identified as an Hsp90 interactor in a Y2H screen 
(Krishna et al., unpublished data), confirmation of this interaction was required using 
full-length proteins. Here we confirmed the interaction of full-length ERS2 with Hsp90 
in a targeted Y2H assay. Interaction between Hsp90 and ERS2 led to the activation of 
the reporter gene (HIS3), which allowed transformants to grow on the dropout agar 
medium (-Leu -T rp -H is) in the presence o f 3 mM 3AT. Under similar stringent 
conditions we also demonstrated physical interaction between CTR1 and ERS2, which 
has previously been implicated through genetic studies but not shown until now. CTR1, 
a Raf-like kinase and the immediate downstream component in the ethylene signalling 
pathway in A. thaliana, has been demonstrated to interact directly with ETR1, ERS1 and 
ETR2 members of the ethylene receptor family (Clark et al., 1998; Gao et al., 2003; 
Cancel & Larsen, 2002). Direct interaction of CTR1 with ERS2 and EIN4 has not been 
reported, although genetic evidence based on mutant analysis has indicated a role of 
subfamily II ethylene receptors in membrane localization of CTR1 (Gao et al., 2003).
A limiting factor o f the Y2H assay is that it detects interaction in the nucleus. Since 
ERS2 is an ER-localised protein, we needed to demonstrate its interaction with Hsp90 in 
plant cells using BiFC assay which also allows spatial visualization of the interaction 
(Kerppola, 2006).
In earlier studies, the ethylene receptors have been localized to the ER using 
biochemical techniques (Chen et al., 2007), as well as BiFC (Dong et al., 2010; Grefen 
et al., 2008). Our localization results with ERS2-full-length YFP closely matched the
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previously observed localization patterns for ERS1, ERS2 and EIN4 in tobacco 
epidermal leaf cells (Grefen et al., 2008). Grefen et al., (2008) reported fluorescence 
signal around the nucleus for ERS2, ERS1 and EIN4. We also observed fluorescence 
around the nucleus in our study (Figure 8, close up image). We consistently observed 
the same localization o f ERS2 independent of whether the YFP was fused to the N- or 
the C-terminus of the receptor, indicating that the YFP tag does not cause 
mislocalization o f the protein. Furthermore, the Hsp90-ERS2 association also showed 
the same distribution, irrespective of the combination used, ERS2-nYFP+Hsp90-cYFP or 
ERS2-cYFP+ Hsp90-nYFP. Thus, while an ER-localized marker should have been used 
as a positive control, all together our results strongly suggest that ERS2 interacts with 
Hsp90 in planta and this interaction might localize to the ER.
4-3 Radicicol alters both transcript and protein levels of ERS2 
Radicicol (RA) inhibits Hsp90 function by binding to its N-terminal ATP binding 
pocket (Trepel et al., 2010). The Hsp90-client protein interaction disrupted by Hsp90 
inhibitors such as GA and RA, leads to destabilization and degradation o f client proteins 
via the proteasome pathway (Trepel et al., 2010). Examples of this can be seen in 
Epidermal growth factor receptor, ERBB3 (Gerbin & Landgraf, 2010), Death associated 
protein kinase, DAPK (Zhang et al., 2007), Mitogen activated protein kinase kinase3, 
MEKK3 (Fang et al., 2009), endothelial Nitric Oxide Synthase (eNOS) (Gracia et al., 
1998) BCL-6 (Cerchietti et al., 2009), and Interferone regulatory factor 1, IRF1 
(Narayan et al., 2009). The effect o f RA on the cellular levels of ERS2 was more 
complicated than simply describing it as protein turnover. RA affected both ERS2 
transcript and protein steady state levels. The protein levels were decreased though not
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completely abolished by RA, suggesting that only a proportion of ERS2 may be 
associated with Hsp90. Strong evidence in favour of this notion was derived from results 
shown in Figure 13 whereby the proteasome inhibitors could prevent the RA-induced 
reduction in ERS2 levels at an early time point in the experiment. For the ERS2 levels 
remaining at 2 h, it is difficult to say what proportion, if any, was derived from the 
previously Hsp90-associated ERS2 that continued to be stabilised by the proteasome 
inhibitors.
The overall decline in the levels of TAP-tagged ERS2 in the presence of proteasome 
inhibitors can be rationalised as follows:
The ethylene signalling pathway consists o f multiple regulatory networks at both 
transcriptional and post-transcriptional levels (Zhao & Guo, 2011); some of these may 
be affected by RA, consequently influencing ERS2 transcript expression or ERS2 
protein synthesis. These would account as indirect or secondary effects of RA. Since we 
have found Hsp90 to interact with CTR1 (Lehrer et al., unpublished data) and EIN3 
(present study), both o f which are important players in ethylene signalling, it is possible 
that the effect of RA on these proteins, converges on ERS2 transcript level, which itself 
is an ethylene-responsive gene.
The regulatory role o f Hsp90 on its clients could also be influenced by extrinsic factors 
such as interactions with other proteins and cell signalling events. Such context- 
dependent interactions have been reported for eNOS where destabilization o f eNOS 
upon Hsp90 inhibition by GA is influenced by various signals including the presence of 
histamine and vascular endothelial cell growth factor (Gracia et al., 1998). Furthermore, 
Yamada et al., (2007) reported that RA, and to a lesser extent GA treatment altered
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mRNA levels of 157 genes. Thus, the effect of Hsp90 inhibition by RA on ERS2 could 
be multifactorial.
It is also important to note that in response to RA, the TAP-tagged ERS2 levels profile 
did not completely match ERS2 transcript levels profile, which remained essentially 
unchanged after 1 h (Figure 10). At the protein level, since TAP-tagged ERS2 levels 
were first enhanced by ACC treatment, prior to RA treatment, the earlier time points of 
our experiments highlight the post-translational effect of RA on TAP-tagged ERS2 
versus its do novo synthesis resulting from transcription. It is this portion of the total 
TAP-tagged ERS2 that is prevented from degradation by the proteasome inhibitors 
within the first 30 minutes. The remaining portion of TAP-tagged ERS2 may not be 
bound to Hsp90 and may be stored in complex with proteins other than Hsp90 that is not 
targeted for degradation.
Clearly, with ERS2 being an ethylene response gene and with the possibility that some 
downstream components of the ethylene signalling pathway may also be Hsp90 clients, 
we are faced with a much more complex situation in demonstrating that ERS2 is a client 
protein o f Hsp90. Nevertheless, the clear demonstration of ERS2-Hsp90 interaction by 
two different approaches, together with the stabilization of ERS2 levels by proteasome 
inhibitors in the presence of RA, are strong indications endorsing this relationship which 
when disrupted by RA, targets a fraction of the receptor to proteasome mediated 
degradation (Figure 13). These results strongly suggest that ERS2 is a typical client 
protein o f Hsp90.
4-4 Hsp90 inhibition induces proteasome-dependent degradation of ERS2 in planta
Since with western blotting we were able to detect RA effect on TAP-tagged ERS2
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protein levels, but not on Hsp90-ERS2 interaction per se, we decided to trace this effect 
in planta using BiFC. The fluorescence signal arising from ERS2-Hsp90 interaction got 
weak within an hour and was nearly abolished by 6 h of RA treatment (Figure 14). This 
time course experiment revealed that dynamic changes in Hsp90-ERS2 interaction 
occurred in response to RA that cannot be explained by changes in ERS2 transcript 
levels (Figure 10). The BiFC experiments did not involve prior induction with ACC. 
Nevertheless, the results of BiFC and western blotting were consistent in that RA 
destabilized Hsp90-ERS2 interaction within 30 min and the proteasome inhibitors 
prevented this effect, supporting the model in which ERS2 is degraded in a proteasome- 
dependent manner in response to Hsp90 inhibition. Since RA did not affect dimerization 
of Dwarf!, its effect on Hsp90-ERS2 interaction appears to be specific and does not 
arise from RA decreasing the association o f any two interacting proteins in BiFC assay. 
The results o f BiFC assay closely matched those of western blotting (Figure 13), 
providing confirmatory proof that disruption o f Hsp90-ERS2 complex by RA leads to 
proteasomal degradation of proteins (Figure 14). Quantification of ERS2-YFP levels in 
tobacco leaves by western blotting in the future can demonstrate that the ERS2-Hsp90 
interaction falls apart due to ERS2-YFP being degraded.
4-5 ERS2 interacts with Hsp90 via its Kinase domain
One of the major groups of Hsp90 clients are protein kinases that play significant roles 
in signalling pathways. Some of them interact with Hsp90 through their kinase domain 
(Xu et al., 2005; Citri et al., 2006; Zhang et al., 2007; Gebin & Landgraf, 2010). 
Ethylene receptors have a histidine kinase (HK) domain, which is similar to the bacterial 
two-component phosphorelay signalling system (Chang & Stadler, 2001). It has been
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established that the HK domain is needed for physical interaction with CTR1 (Gao et al., 
2003). Subfamily II receptors, including ERS2, have a degenerate HK domain that acts 
as a Serine/Threonine kinase and can phosphorylate Hsp70 in the presence of Mg 
(Moussatche & Klee, 2004). In bacteria the HK domain consists of five consensus 
motifs (H, N, G l, F and G2) that are essential for the kinase activity (Parkinson & 
Kofoid, 1992). Sequence alignment of A. thaliana ethylene receptor kinase domains has 
revealed that F box is not conserved in any of the receptors, and Gl-box motif is not 
recognizable in subfamily II receptors (ETR2, ERS2 and EIN4). Furthermore, ERS2 and 
ETR2 lack the consensus residue H in the H box, but, similar to other ethylene 
receptors, possess conserved amino acid residues in the N box which are essential for 
their kinase activity (Gao et al., 2008; Qu & Schaller, 2004; Moussatche & Klee, 2004). 
Based on these findings, we made a series o f truncated ERS2 proteins to determine what 
region is responsible for binding Hsp90 (Figure 5). Each truncated ERS2 protein was 
fused with either full-length YFP to confirm localization or half YFP to test its 
interaction with Hsp90. All fusions with full-length YFP showed ER localization. 
Interestingly neither the truncated ERS2 protein lacking the entire kinase domain 
(ERS2A359-645) nor the protein lacking part of it (ERS2A463-645) could bind Hsp90. 
Only the protein in which the N box was retained (ERS2A563-645) interacted with 
Hsp90, suggesting that amino acids between 463 and 562 within the kinase domain are 
essential for this interaction. The impact of N-terminal deletions on ERS2 ability to 
interact with Hsp90 was not tested in the present study and could be taken up in the 
future to further dissect the interaction between the two proteins. These results not only 
mapped the region o f interaction, but also confirmed the specificity of ERS2-Hsp90
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interaction in the BiFC assay.
4-6 ERS2 interacts with two novel co-chaperones of Hsp90, TPR1 and TPR2
Hsp90 client proteins exist as multiprotein complexes together with molecular 
chaperones and their co-chaperones. Since AtTPRl and SITPR1 are involved in early 
stages o f ethylene signalling by interacting with ERS1 (Lin et al., 2009) and LeETRl 
(Lin et al., 2008), respectively, and AtTPRl and AtTPR2 interact with Hsp90 (Prasad et 
al., 2010; Krishna & coworkers unpublished data), we determined the interaction of 
TPR1 and TPR2 with Hsp90 in BiFC. Both proteins interacted with ERS2 in planta. 
Plugging this information in the big picture of ERS2-Hsp90 interaction, we can assume 
that a multiprotein complex containing Hsp90-ERS2-TPR1 or TPR2 and other 
unidentified proteins regulates ERS2. Lin et al., (2009) proposed that TPR1 is involved 
in inactivating ERS1, leading to its dissociation from CTR1 consequently derepressing 
ethylene responses. It is possible that the Hsp90-TPR1/TPR2 complex assists interaction 
o f ERS2 with CTR1 in planta. This requirement in the Y2H assay would have been 
fulfilled by yeast Hsp90, leading to ERS2-CTR1 interaction. An in vitro assembly of 
ERS2 with various components in the future can help in understanding the roles o f each 
component.
The fact that ERS2 was able to interact with TPR2 in both combinations, but in the case 
of TPR1 only with TPRl-nYFP, implies differences in the 3-dimentional conformations 
o f fusion proteins, some o f which may not be optimal for complex formation.
In conclusion, three lines of evidence suggest that ERS2 acts like an Hsp90 client 
protein: 1) interaction o f ERS2 with Hsp90 in yeast and in planta-, 2) inhibitory effect of 
RA on ERS2 steady state levels and partial reversal o f this effect by proteasome
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inhibitors; 3) interaction of ERS2 with Hsp90 co-chaperones. In the future, experiments 
are required to shed light on the significance of these interactions in ethylene response 
regulation.
4.7 Hsp90 interacts with EIN3 in plata
Since Ethylene Insensitive 3 (EIN3), a key transcription factor in ethylene pathway, is 
tightly regulated at protein level (Zhao & Guo, 2011), it implies a significant role for 
EIN3 in ethylene signalling. In animal systems, transcription factors are among Hsp90 
clientele (Pearl et al., 2008). Nearly 3% of the Hsp90 pool in the cell is found in the 
nucleus, indicating the role of this chaperone in nuclear events (Csermely et al., 1998). 
There are several examples o f Hsp90’s association with transcription factors in the 
nucleus, such as steroid hormone receptors (Echeverria & Picard, 2010), heat shock 
transcription factor HSF1 (Conde et al., 2009), and mammalian Interferone Regulatory 
Factor 1 (IRF1) (Narayan et al., 2009). Hsp90 binds to IRF1 in the nucleus and this 
protein complex regulates IRF1 target genes. Since EIN3 is a transcription factor and 
tightly regulated at the protein level we hypothesised that EIN3 might interact with 
Hsp90. As a transcription factor, EIN3 localises to the nucleus (Guo & Ecker, 2003). In 
accordance with its known subcellular localization, EIN3-full-length YFP localized to 
the nucleus (Figure 17). Furthermore, EIN3 interacted with Hsp90 in the nucleus, 
although DAPI staining is required to stain nuclei to confirm the localization. Although, 
Hsp90 localizes mainly to the cytoplasm and does not have a nuclear localization signal 
(NLS), it is able to co-localize in the nucleus along with a nucleus-localized partner. 
This was shown in onion epidermal cells by BiFC (Yamada et al., 2007), as well as for 
human Hsp90 with its client protein histone methyltransferase SYMD3 (Hamamoto et
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al., 2004) and a chromatin-modifying enzyme PRMT5 (Maloney et al., 2007). More 
work is clearly needed to test whether EIN3 is a potential client protein of Hsp90. The 
authenticity of this interaction and its biological significance can be investigated in the 
future.
4-8 Concluding remarks and future directions
This study provides the first identification and initial characterization of the protein- 
protein interactions of two proteins with Hsp90 in A. thaliana: ERS2 as a membrane 
bound receptor and EIN3 as a transcription factor both play significant roles in ethylene 
signal transduction. The experiments performed in this study showed that:
(1) ERS2 is able to form a complex with Hsp90 in planta in tobacco epidermal leaf 
cells. This is the first clear evidence of an association between Hsp90 and a membrane 
bound receptor in plants involved in the regulation o f ethylene hormone signalling 
pathway. To study the biological significance of Hsp90-ERS2 interaction, investigation 
o f Hsp90 function could be accomplished through mutational analysis of Hsp90 gene 
members as well as double and triple mutant generation between TAP-tagged ERS2 
plants and several of the Hsp90 mutant lines. Such mutations should display more 
severe growth phenotypes in response to ACC.
(2) The ER localization of ethylene receptors have been shown previously using an ER 
marker protein in BiFC assay and the membrane recruitment assay (MeRA), which is an 
alternative to BiFC (Grefen et al., 2008). MeRA is based on a RFP-fluorescent anchor 
protein which is localized in a membrane compartment such as the ER and a GFP- or 
YFP- fluorescent ‘prey’ protein. If the fusion proteins interact, the membrane-bound 
anchor protein recruits the prey protein to the membrane compartment. In our study, we
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have not used an ER marker thus we cannot be certain that the Hsp90-ERS2 interaction 
is localized to the ER membrane. However, in the future, it could be helpful to use the 
MeRA technique or to use a protein known to be ER-localized with RFP or GFP to 
visualize overlays with ERS2-YFP.
(3) The interaction of Hsp90 with ERS2 is abated by RA and this effect specifically acts 
on Hsp90-ERS2 association, implying that ERS2 is dependent on Hsp90 for its stability. 
This finding can be confirmed by using anti-YFP antibody to detect ERS2-YFP levels in 
tobacco cells by western blotting following RA treatment.
(4) Disruption of Hsp90-ERS2 interaction via RA results in ERS2 degradation through 
the proteasome pathway suggesting that ERS2 is a client protein. Since proteasomal 
degradation is linked to polyubiquitination, ERS2 proteins could also be captured in the 
ubiquitynated form in the presence o f proteasome inhibitors using anti-ubiquitin 
antibody. Polyubiquitination can be confirmed by checking the laddering pattern for 
ERS2 protein.
(5) ERS2 interacts with TPR1 and TPR2 which are co-chaperones of Hsp90. To further 
examine the natural protein profiles associating Hsp90-ERS2 complex, experiments are 
required to compare proteins isolated from samples treated with RA versus control 
seedlings. Quantitative analysis of proteomic changes should be carried out using two- 
dimensional gel electrophoresis coupled with mass spectrometry. By this strategy 
proteins present in the ERS2-Hsp90 multiprotein complex will be identified. Co-IP with 
total protein extracts is an alternative approach to addressing this question as the YFP 
fusion proteins include either Flag or HA epitope tags (Earley et al., 2006), these 
constructs could be used to perform Co-IP experiments with specific antibodies.
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(6) The C-terminal kinase domain o f ERS2 is responsible for binding Hsp90. Protein- 
protein interaction requires intermolecular interactions which involve specific amino 
acids in each protein. Crystallization techniques have enabled researchers to predict 
amino acids that might be involved in these interactions, however, simpler and more 
reliable techniques are available. Determining which amino acids are required within the 
ERS2 kinase domain for binding Hsp90 could be achieved by site-directed mutagenesis 
to alter specific amino acids between residues 463 and 562 thus far predicted to be 
involved in this interaction. Although in most cases small changes are sufficient to 
destroy an interaction site, it is likely that more than one substitution will be required to 
completely abolish the interaction.
(7) In this study, we found that Hsp90 interacts with EIN3 in the nucleus. This finding 
is a stepping stone for further experiments to clarify the nature o f this interaction and 
whether EIN3 is dependent on Hsp90 as a putative client protein. If Hsp90 performs an 
important regulatory step in different stages o f ethylene signaling pathway, then it is 
critical to understand when and how Hsp90 functions in the regulation and transduction 
o f ethylene signal through downstream components. Ethylene is one of the most 
commercially-important plant regulators, because of its role in fruit ripening and stress 
response. The ability to manipulate ethylene signaling in plants is an important step to 
the possible downstream applications of this finding. More work is needed to improve 
our knowledge about the significance o f these interactions and to apply them in a 
physiologically relevant manner.
In summary, the results o f my studies demonstrate that 1) Hsp90 interacts with ERS2, in 
both Y2H and BiFC assays; 2) ERS2 protein levels decrease by treatment with RA, but
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this can be averted in the presence of proteasome inhibitors, indicating that Hsp90 
stabilizes ERS2 and that disruption o f ERS2-Hsp90 complex causes ERS2 to degrade by 
the proteasomal degradation pathway; 3) TPR1 and TPR2 interact with ERS2 in BiFC 
assay; 4) EIN3 localises to the nucleus and interacts with Hsp90 in the nucleus in BiFC 
assay. Together, these findings provide solid evidence that Hsp90 is involved in the 
ethylene signalling pathway through stabilizing ERS2 and possibly through an effect on 
EIN3. Based on this study, we can propose a general model for the involvement of 
Hsp90 in the early stages of the ethylene signaling pathway: In the absence of ethylene, 
ERS2 is associated with Hsp90 and most likely with CTR1 in an either direct or indirect 
interaction; Hsp90 might act as a scaffold between ERS2 and CTRL Upon binding 
ethylene to the receptor, a conformational change is occurred, causing CTR1 to 
dissociate and TPR1 to be recruited to the ERS2-Hsp90 complex leading to inactivation 
of ERS2, and its proteasomal degradation. Most likely, there are more interacting 
proteins in the complex acting as co-chaperones yet to be identified.
This study identifies the second client protein of Hsp90 in plants and lays the foundation 
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Supplementary Figure 1: Confocal microscopy images from negative controls for BiFC. 
None of the constructs are able to self-fluoresce in the absence of the interacting proteins
in tobacco epidermal leaf cells.
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Supplementary Figure 2: Confocal microscopy images from chlorophyll and bright field 
channels for Dwarfl dimerization in BiFC.
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Supplementary Figure 3: Confocal microscopy images from chlorophyll and bright field 
channels for ERS2-nYFP+Hsp90-cYFP in tobacco epidermal leaf cells treated with RA.
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ERS2-nYFP+ Hsp90-cYFP
Supplementary Figure 4: Confocal microscopy images from chlorophyll and bright field 
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Supplementary Figure 5: Confocal microscopy images from chlorophyll and bright field 
channels for truncated versions of ERS2 in tobacco epidermal leaf cells.
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